2018
DOI: 10.1097/01.ewx.0000546356.40865.e4
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 36 gamma in psoriasis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Symptoms of leprosy may appear within a year, but for some people, symptoms may take 20 years or more to occur, (Farag et al, 2022). House contacts with leprosy cases are at the highest risk, (Tió-Coma et al, 2021).…”
Section: Resultsmentioning
confidence: 99%
“…Symptoms of leprosy may appear within a year, but for some people, symptoms may take 20 years or more to occur, (Farag et al, 2022). House contacts with leprosy cases are at the highest risk, (Tió-Coma et al, 2021).…”
Section: Resultsmentioning
confidence: 99%
“…A retrospective immunohistochemical study of psoriatic lesions of 40 patients with psoriasis and matched controls demonstrated that IL-36γ was strongly expressed (in four or more layers) in the nuclei of suprabasal epidermal keratinocytes, while, in all controls, weak cytoplasmic expression was detected in the basal layer. Additionally, the elevated IL-36γ expression was significantly associated with psoriasis severity [ 41 ].…”
Section: Il-36 As a Central Node In Gpp Pathogenesismentioning
confidence: 99%